Literature DB >> 31754794

18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!

Giorgio Treglia1,2, Luca Giovanella3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31754794     DOI： 10.1007/s00259-019-04563-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.

Authors:  Giorgio Treglia; Cumali Aktolun; Arturo Chiti; Savvas Frangos; Luca Giovanella; Martha Hoffmann; Ioannis Iakovou; Jasna Mihailovic; Bernd J Krause; Werner Langsteger; Frederik A Verburg; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-27       Impact factor: 9.236

3.  Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

Authors:  Paulo Schiavom Duarte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

4.  EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

Authors:  Luca Giovanella; Giorgio Treglia; Ioannis Iakovou; Jasna Mihailovic; Frederik A Verburg; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

Review 5.  Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus.

Authors:  Dirk Bassler; Katharina F Mueller; Matthias Briel; Jos Kleijnen; Ana Marusic; Elizabeth Wager; Gerd Antes; Erik von Elm; Douglas G Altman; Joerg J Meerpohl
Journal:  BMJ Open       Date:  2016-01-21       Impact factor: 2.692

6.  New evidence pyramid.

Authors:  M Hassan Murad; Noor Asi; Mouaz Alsawas; Fares Alahdab
Journal:  Evid Based Med       Date:  2016-06-23
  6 in total
  2 in total

Review 1.  Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives.

Authors:  Michele Klain; Julien Hadoux; Carmela Nappi; Monica Finessi; Raffaele Ambrosio; Martin Schlumberger; Alberto Cuocolo; Désirée Deandreis; Domenico Salvatore
Journal:  Endocrine       Date:  2021-11-08       Impact factor: 3.633

2.  Comparison of 18F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases.

Authors:  Cristina Emiko Ueda; Paulo Schiavom Duarte; Luciana Audi de Castroneves; George Barbério Coura-Filho; Heitor Naoki Sado; Marcelo Tatit Sapienza; Ana Oliveira Hoff; Carlos Alberto Buchpiguel
Journal:  Nucl Med Mol Imaging       Date:  2020-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.